Trending Topics

FDA to review OTC Narcan spray

The overdose treatment could be more widely available in spring

AP20002625842015.jpg

File photo/Keith Srakocic/Associated Press

By Leila Merrill
EMS1

GAITHERSBURG, Md. — Emergent BioSolutions Inc. announced this month that the FDA accepted for review its supplemental new drug application for Narcan nasal spray as an over-the-counter emergency treatment.

The overdose treatment could become available over the counter as soon as March 29.

“We are taking to this step to help address the rising and devastating number of opioid overdoses and fatalities happening across the country,” Emergent CEO Robert Kramer said in a statement.